Meeting of the Advisory Committee on Infant Mortality, 29464 [2020-10447]
Download as PDF
<![CDATA[
29464
Federal Register / Vol. 85, No. 95 / Friday, May 15, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Infant Mortality
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
Advisory Committee on Infant Mortality
(ACIM) has scheduled a public meeting.
Information about ACIM and the agenda
for this meeting can be found on the
ACIM website at https://www.hrsa.gov/
advisory-committees/infant-mortality/
index.html.
SUMMARY:
June 17, 2020, 11:00 a.m.–6:00
p.m. Eastern Time (ET) and June 18,
2020, 11:00 a.m.–3:00 p.m. ET.
ADDRESSES: This meeting will be held
via webinar.
• The webinar link will be available
at ACIM’s website 7 calendar days
before the meeting: https://
www.hrsa.gov/advisory-committees/
infant-mortality/.
• The conference call-in number will
be available at ACIM’s website 7
calendar days before the meeting:
https://www.hrsa.gov/advisorycommittees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT:
Juliann DeStefano, RN, MPH, at
Maternal and Child Health Bureau
(MCHB), HRSA, 5600 Fishers Lane,
Room 18N–84, Rockville, Maryland
20857; 301–443–0883; or SACIM@
hrsa.gov.
DATES:
The ACIM
is authorized by section 222 of the
Public Health Service Act (42 U.S.C.
217a), as amended. The Committee is
governed by provisions of Public Law
92–463, as amended, (5 U.S.C. App. 2),
which sets forth standards for the
formation and use of Advisory
Committees.
The ACIM advises the Secretary of
HHS on department activities and
programs directed at reducing infant
mortality and improving the health
status of pregnant women and infants.
The ACIM represents a public-private
partnership at the highest level to
provide guidance and focus attention on
the policies and resources required to
address the reduction of infant mortality
and the improvement of the health
status of pregnant women and infants.
With a focus on life course, the ACIM
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:09 May 14, 2020
Jkt 250001
addresses disparities in maternal health
to improve maternal health outcomes,
including preventing and reducing
maternal mortality and severe maternal
morbidity. The ACIM provides advice
on how best to coordinate myriad
federal, state, local, and private
programs and efforts that are designed
to deal with the health and social
problems impacting infant mortality and
maternal health, including
implementation of the Healthy Start
program and maternal and infant health
objectives from the National Health
Promotion and Disease Prevention
Objectives.
The agenda for the June 17–18, 2020,
meeting is being finalized and may
include the following: Updates from
HRSA and MCHB, discussion of
COVID–19 and infant and maternal
health, and updates on priority topic
areas for ACIM to address (equity, data,
access, and quality of care). Agenda
items are subject to change as priorities
dictate. The final meeting agenda will
be available 7 calendar days prior to the
meeting on the ACIM website: https://
www.hrsa.gov/advisory-committees/
infant-mortality/.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to the ACIM
should be sent to Juliann DeStefano,
using the contact information above at
least 3 business days prior to the
meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Juliann DeStefano at the contact
information listed above at least 10
business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
meeting of the Board of Scientific
Counselors, NICHD.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
EUNICE KENNEDY SHRIVER
NATIONAL INSTITUTE OF CHILD
HEALTH & HUMAN DEVELOPMENT,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NICHD.
Date: June 5, 2020.
Time: 10:00 a.m. to 2:45 p.m.
Agenda: A report by the Acting Scientific
Director, NICHD, on the status of the NICHD
Division of Intramural Research; current
organizational structure; to review and
evaluate personnel qualifications and
performance, and competence of individual
investigators.
Place: National Institutes of Health, 31
Center Drive, Bethesda, MD 20892
(Teleconference).
Contact Person: Mary C. Dasso, Ph.D.,
Acting Scientific Director, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, NIH, 9000 Rockville
Pike, Building 31A, Room 2A46, Bethesda,
MD 20892, (301) 594–5984, dassom@
mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/meetings/Pages/
index.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: May 11, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–10429 Filed 5–14–20; 8:45 am]
[FR Doc. 2020–10447 Filed 5–14–20; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 85, Number 95 (Friday, May 15, 2020)]
[Notices]
[Page 29464]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10447]
[[Page 29464]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Infant Mortality
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Advisory Committee on Infant
Mortality (ACIM) has scheduled a public meeting. Information about ACIM
and the agenda for this meeting can be found on the ACIM website at
https://www.hrsa.gov/advisory-committees/infant-mortality/.
DATES: June 17, 2020, 11:00 a.m.-6:00 p.m. Eastern Time (ET) and June
18, 2020, 11:00 a.m.-3:00 p.m. ET.
ADDRESSES: This meeting will be held via webinar.
The webinar link will be available at ACIM's website 7
calendar days before the meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/.
The conference call-in number will be available at ACIM's
website 7 calendar days before the meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT: Juliann DeStefano, RN, MPH, at
Maternal and Child Health Bureau (MCHB), HRSA, 5600 Fishers Lane, Room
18N-84, Rockville, Maryland 20857; 301-443-0883; or [email protected].
SUPPLEMENTARY INFORMATION: The ACIM is authorized by section 222 of the
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee
is governed by provisions of Public Law 92-463, as amended, (5 U.S.C.
App. 2), which sets forth standards for the formation and use of
Advisory Committees.
The ACIM advises the Secretary of HHS on department activities and
programs directed at reducing infant mortality and improving the health
status of pregnant women and infants. The ACIM represents a public-
private partnership at the highest level to provide guidance and focus
attention on the policies and resources required to address the
reduction of infant mortality and the improvement of the health status
of pregnant women and infants. With a focus on life course, the ACIM
addresses disparities in maternal health to improve maternal health
outcomes, including preventing and reducing maternal mortality and
severe maternal morbidity. The ACIM provides advice on how best to
coordinate myriad federal, state, local, and private programs and
efforts that are designed to deal with the health and social problems
impacting infant mortality and maternal health, including
implementation of the Healthy Start program and maternal and infant
health objectives from the National Health Promotion and Disease
Prevention Objectives.
The agenda for the June 17-18, 2020, meeting is being finalized and
may include the following: Updates from HRSA and MCHB, discussion of
COVID-19 and infant and maternal health, and updates on priority topic
areas for ACIM to address (equity, data, access, and quality of care).
Agenda items are subject to change as priorities dictate. The final
meeting agenda will be available 7 calendar days prior to the meeting
on the ACIM website: https://www.hrsa.gov/advisory-committees/infant-mortality/.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to the ACIM should be
sent to Juliann DeStefano, using the contact information above at least
3 business days prior to the meeting.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Juliann DeStefano at the
contact information listed above at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-10447 Filed 5-14-20; 8:45 am]
BILLING CODE 4165-15-P
